Additionally, β‐blockers contribute to the improvement in ventricular remodeling markers: The decrease in BNP, a marker of ventricular wall stress, may signify the role of β‐blockers in inhibiting myocardial fibrosis and retarding ventricular remodeling [21]. This evidence concerns the gene NPPB and Myocardial fibrosis.